What is Sarepta Therapeutics, Inc.'s stock issuance proceeds?

Sarepta Therapeutics, Inc. (SRPT) reported stock issuance proceeds of $241K in Q1 2026.

How has Sarepta Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?

Sarepta Therapeutics, Inc.'s stock issuance proceeds decreased by 98.5% year-over-year, from $15.68M to $241K.

What does stock issuance proceeds mean?

Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.

Sarepta Therapeutics, Inc. SRPT Stock Issuance Proceeds

Stock Issuance Proceeds at other companies

Regeneron PharmaceuticalsREGN

$163.1M+169%

PTC TherapeuticsPTCT

$6.4M-59.3%

InsmedINSM

$30.31M+2.1%

Capricor TherapeuticsCAPR

$1.47M+2,821%

Catalyst PharmaceuticalCPRX

$3.3M—

uniQureQURE

$550K+246%

Other financials

Income statement

See full

Revenue$730.8M-1.9%

Operating income-$300.4M-961%

Net income$331.0M+174%

EPS (diluted)-$4.60-1,343%

Balance sheet

See full

Cash & equivalents$464.5M+92.8%

Total debt$198.5M-3.4%

Total equity$1.5B+31.7%

Total assets$3.2B-8.3%

Cash flow

See full

Operating cash flow-$202.7M+65.3%

CapEx$2.1M-95.2%

Free cash flow-$204.8M+67.3%

Valuation

See full

Market cap$1.76B-63.1%

Profitability

See full

Operating margin-50.8%-1.6pp

Net margin4.6%+2.4pp

FCF margin-28.7%-9.2pp

Returns & leverage

See full

Return on equity-23.6%-28.5pp

Debt / equity0.1×0.0×

Current ratio4.6×+0.6×

Where this comes from

Reported directly by Sarepta Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.

The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sarepta Therapeutics, Inc.'s stock issuance proceeds.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sarepta Therapeutics, Inc.'s stock issuance proceeds?: Sarepta Therapeutics, Inc. (SRPT) reported stock issuance proceeds of $241K in Q1 2026.
How has Sarepta Therapeutics, Inc.'s stock issuance proceeds changed year-over-year?: Sarepta Therapeutics, Inc.'s stock issuance proceeds decreased by 98.5% year-over-year, from $15.68M to $241K.
What does stock issuance proceeds mean?: Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.